Jiangsu wuzhong(SH:600200)2022-10-28 16:00Financial Performance - The company's operating revenue for Q3 2022 was ¥594,281,822.27, representing a year-on-year increase of 37.19%[7] - The net profit attributable to shareholders was -¥27,415,072.91, with a year-to-date net profit of -¥46,827,361.12, reflecting a decrease of 194.81% compared to the same period last year[7] - The basic earnings per share for the quarter was -¥0.039, a decrease of 195.27% year-on-year[9] - Total revenue for the first three quarters of 2022 was CNY 1,380,375,163.96, a decrease of 5.93% compared to CNY 1,467,782,116.49 in the same period of 2021[30] - Net profit for Q3 2022 was a loss of CNY 48,381,746.93, compared to a profit of CNY 47,910,931.43 in Q3 2021, indicating a significant decline[33] - The net profit attributable to the parent company was -$46.83 million, compared to a profit of $49.39 million in the same period last year, indicating a significant decline[37] - The total comprehensive income amounted to -$49.08 million, down from $32.77 million year-over-year[37] - The basic and diluted earnings per share were both -$0.066, compared to $0.069 in the previous year[39] Assets and Liabilities - The total assets at the end of the reporting period were ¥3,823,823,724.11, an increase of 1.74% from the end of the previous year[9] - Total current assets as of September 30, 2022, amounted to RMB 2,739,426,823.28, an increase from RMB 2,684,319,610.62 as of December 31, 2021, reflecting a growth of approximately 2.05%[25] - Total liabilities reached CNY 1,975,015,526.92 in Q3 2022, up from CNY 1,881,410,098.21, reflecting an increase of 4.99%[30] - Non-current assets totaled CNY 1,084,396,900.83, slightly up from CNY 1,074,018,034.94, indicating a growth of 0.30%[30] Cash Flow - The net cash flow from operating activities for the year-to-date was -¥161,602,511.28, indicating a significant decline in cash inflow[9] - Cash flow from operating activities generated a net outflow of -$161.60 million, a decrease from a net inflow of $291.74 million in the same period last year[39] - Cash inflow from investment activities was $272.08 million, up from $207.72 million year-over-year[42] - Cash flow from financing activities resulted in a net inflow of $179.50 million, compared to $111.62 million in the previous year[42] - The ending balance of cash and cash equivalents was $1.25 billion, an increase from $1.06 billion at the end of the previous year[42] Investments and Expenses - Research and development expenses for Q3 2022 amounted to CNY 22,237,239.07, an increase from CNY 18,244,320.92 in Q3 2021, representing a growth of 21.83%[33] - The company received government subsidies amounting to ¥247,424.64 during the quarter, primarily related to its pharmaceutical business[11] - The company received a total of RMB 298,534,345.93 in exit compensation from the Jiangsu Xiangshui Ecological Chemical Park Management Committee, out of a total compensation of RMB 384,555,277.93[21] Changes in Accounts - The company reported a 30.77% increase in prepaid accounts, attributed to increased procurement payments[14] - The company experienced a 723.27% increase in other receivables due to compensation payments from a subsidiary[14] - Accounts receivable increased to RMB 919,066,487.34 from RMB 759,968,112.40, representing a growth of approximately 20.93%[25] - Other receivables rose sharply to RMB 101,998,332.46 from RMB 12,389,438.11, marking an increase of around 726.5%[25] - The company reported a decrease in accounts payable from CNY 131,756,572.16 to CNY 105,173,460.43, a reduction of 20.29%[30] Equity and Ownership - The company’s total equity attributable to shareholders was ¥1,828,448,481.45, a decrease of 1.43% from the previous year[9] - The company’s weighted average return on equity was -1.51%, a decrease of 0.45 percentage points from the previous year[9] - There are no known related party transactions among the top shareholders, ensuring transparency in ownership structure[20] General Remarks - The company has not disclosed any significant new product developments or market expansions during the reporting period[21] - The company plans to continue focusing on R&D to drive future growth despite current losses[33]